Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Aoli Pharmaceutical is a specialized pharmaceutical manufacturer based in Chongqing, China, and operates as a key subsidiary of Chongqing Pharscin Pharmaceutical. The company focuses on the development and production of chemical drugs and traditional Chinese medicine formulations, with a strong emphasis on cardiovascular and gastrointestinal health. Its manufacturing facilities are fully GMP-certified, supporting the production of widely used medications such as amlodipine besylate and omeprazole. Chongqing Aoli integrates research and development with large-scale industrial production to supply both domestic and international markets. The firm is recognized as a high-tech enterprise, contributing significantly to the regional pharmaceutical industry through its diverse product portfolio and commitment to quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Aoli.